AAAAAA
Results:
1-13
|
Results: 13
Authors:
HUEBERT ND
SCHWARTZ JJ
HAEGELE KD
Citation: Nd. Huebert et al., ANALYSIS OF 2-DIFLUOROMETHYL-DL-ORNITHINE IN HUMAN PLASMA, CEREBROSPINAL-FLUID AND URINE BY CATION-EXCHANGE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography, 762(1-2), 1997, pp. 293-298
Authors:
DAGE JL
ACKERMANN BL
BARBUCH RJ
BERNOTAS RC
OHLWEILER DF
HAEGELE KD
THOMAS CE
Citation: Jl. Dage et al., EVIDENCE FOR A NOVEL PENTYL RADICAL ADDUCT OF THE CYCLIC NITRONE SPINTRAP MDL-101,002, Free radical biology & medicine, 22(5), 1997, pp. 807-812
Authors:
HUEBERT ND
SCHWARTZ JJ
ZEIDLER L
SCHWACH V
HAEGELE KD
Citation: Nd. Huebert et al., SIMULTANEOUS MEASUREMENT OF DOLASETRON AND ITS MAJOR METABOLITE, MDL-74,156, IN HUMAN PLASMA AND URINE, Journal of chromatography B. Biomedical applications, 685(2), 1996, pp. 291-297
Authors:
CORNELIUS KE
FADAYEL GM
BARON BM
SCHMIDT CJ
HAEGELE KD
CHEN TM
Citation: Ke. Cornelius et al., ANALYSIS OF (R)-4-OXO-5-PHOSPHONONORVALINE (MDL-100,453) IN RAT PLASMA AND BRAIN DIALYSATE USING LIQUID-CHROMATOGRAPHY AFTER DERIVATIZATIONWITH 6-AMINOQUINOLYL-N-HYDROXYSUCCINIMIDYL CARBAMATE, Journal of pharmaceutical and biomedical analysis, 14(1-2), 1995, pp. 143-150
Authors:
BERGCANDOLFI M
DULERY B
JEHL F
HAEGELE KD
Citation: M. Bergcandolfi et al., METABOLISM AND PHARMACOKINETICS OF THE CARDIOTONIC AGENT PIROXIMONE AND OF ITS MAJOR METABOLITE IN DOG, Xenobiotica, 25(1), 1995, pp. 59-70
Authors:
DOW J
DULERY BD
HORNSPERGER JM
DIFRANCESCO GF
KESHARY P
HAEGELE KD
Citation: J. Dow et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ACETYLCHOLINESTERASE INHIBITOR 2,2,2-TRIFLUORO-1-(3-TRIMETHYLSILYLPHENYL) ETHANONE IN DOG - POTENTIAL FOR TRANSDERMAL PATCH DELIVERY, Arzneimittel-Forschung, 45-2(12), 1995, pp. 1245-1252
Authors:
SANWALD P
HUEBERT ND
HAEGELE KD
Citation: P. Sanwald et al., SIMULTANEOUS MEASUREMENT OF THE MAJOR METABOLITES OF DOLASETRON MESILATE IN HUMAN URINE USING SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 661(1), 1994, pp. 101-107
Authors:
DOW J
PIRIOU F
WOLF E
DULERY BD
HAEGELE KD
Citation: J. Dow et al., NOVEL CARBAMATE METABOLITES OF MOFEGILINE, A PRIMARY AMINE MONOAMINE-OXIDASE-B INHIBITOR, IN DOGS AND HUMANS, Drug metabolism and disposition, 22(5), 1994, pp. 738-749
Authors:
HUEBERT ND
DULERY BD
SCHOUN J
SCHWACH V
HINZE C
HAEGELE KD
Citation: Nd. Huebert et al., KINETICS AND METABOLISM OF P-TYRAMINE DURING MONOAMINE-OXIDASE INHIBITION BY MOFEGILINE, Clinical pharmacology and therapeutics, 56(5), 1994, pp. 537-542
Authors:
BORLAK JT
HARSANY V
SCHNEBLE H
HAEGELE KD
Citation: Jt. Borlak et al., PNAT AND CYP2D6 GENE POLYMORPHISM IN EPILEPTIC PATIENTS, Biochemical pharmacology, 48(9), 1994, pp. 1717-1720
Authors:
HUEBERT ND
SCHWACH V
RICHTER G
ZREIKA M
HINZE C
HAEGELE KD
Citation: Nd. Huebert et al., THE MEASUREMENT OF BETA-PHENYLETHYLAMINE IN HUMAN PLASMA AND RAT-BRAIN, Analytical biochemistry, 221(1), 1994, pp. 42-47
Authors:
DULERY BD
LEHENANF N
DOW J
HAEGELE KD
Citation: Bd. Dulery et al., DETERMINATION OF AN ACETYLCHOLINESTERASE INHIBITOR, MDL-73745, IN DOGPLASMA AND URINE BY COMBINED GAS-CHROMATOGRAPHY NEGATIVE-ION CHEMICAL-IONIZATION MASS-SPECTROMETRY, Biological mass spectrometry, 22(7), 1993, pp. 377-382
Authors:
PALFREYMAN MG
MCDONALD IA
ZREIKA M
CREMER G
HAEGELE KD
BEY P
Citation: Mg. Palfreyman et al., MDL-72,974A - A SELECTIVE MAO-B INHIBITOR WITH POTENTIAL FOR TREATMENT OF PARKINSONS-DISEASE, Journal of neural transmission, 1993, pp. 101-111
Risultati:
1-13
|